Abstract: A method for monitoring glucose concentration in aqueous humor can include inserting an implantable device into an eye and determining glucose concentration as a function of glucose sensed at the implantable device. The method can optionally include optically detecting glucose concentration as a function of polarimetry and/or fluorescence. A system for monitoring glucose concentration can include devices described herein.

Abstract: Provided herein are systems and methods for treating chronic pain in a patient using virtual reality to modulate the neural plasticity of the patient's brain such that the patient forms an emotional bond to the virtual environment. The systems and methods may further include use of an odor emitter to enhance the user experience.

Abstract: An operating system provides an extensible share action to broker content sharing between applications executing on a computing platform such as a personal computer, tablet computer, or smartphone. The share action enables a consistent user experience for content sharing to be implemented across all applications and eliminates users having to switch from the current application they are using to some other functionality in order to share content. Applications can participate with the operating system share action as source applications and/or target applications. Source applications may describe what content is shareable given the current state of their application when the user chooses to invoke the share action. Target applications can be configured to receive the shared content from the source application according to content type, and will expose a companion view of their application to the user that is specifically tailored to facilitate sharing.

Abstract: An additive manufacturing process includes forming an object material stack using sheet materials without use of binder material between the sheet materials and forming features of the cross-sectional layers of a 3D object in the corresponding sheet materials. Another process involves forming features of the cross-sectional layers of a 3D object in soot layers of a laminated soot sheet. A manufactured article includes three or more glass layers laminated together without any binder material between the glass layers. At least one of the glass layers is composed of silica or doped silica, and at least one feature is formed in at least one of the glass layers.

Abstract: Systems, methods and devices for management of instances of virtual memory components for storing computer readable information for use by at least one first computing device, the system comprising at least one physical computing device, each physical computing device being communicatively coupled over a network and comprising: a physical memory component, a computing processor component, an operating system, a virtual machine monitor, and virtual memory storage appliances; at least one of the virtual memory storage appliances being configured to (a) accept memory instructions from the at least one first computing device, (b) instantiate instances of at least one virtual memory component, (c) allocate memory resources from at least one physical memory component for use by any one of the least one virtual memory components, optionally according to a pre-defined policy; and (d) implement memory instructions on the at least one physical memory component.

Abstract: A thermoelectric system which comprises two substrates spaced apart from each other to form a gap and a plurality of electrically-connected semiconductor elements disposed between the substrates in the gap. The thermoelectric system further comprises at least one sensor and a seal which extends between the substrates and encloses the sensor and at least one of the plurality of semiconductor elements. The sensor is disposed between the substrates at an interior location spaced from the peripheral edge of at least one of the substrates. Additionally, at least one of the semiconductor elements is disposed between the sensor and the peripheral edge.

Abstract: A new variety of sweetpotato, identified as ‘V12B.445’, is disclosed having disease resistance to both fusarium wilt and Streptomyces soil rot; an orange flesh and purple-red skin, and high yield characteristics.

Abstract: A thermoelectric system which comprises two substrates spaced apart from each other to form a gap and a plurality of electrically-connected semiconductor elements disposed between the substrates in the gap. The thermoelectric system further comprises at least one sensor and a seal which extends between the substrates and encloses the sensor and at least one of the plurality of semiconductor elements. The sensor is disposed between the substrates at an interior location spaced from the peripheral edge of at least one of the substrates. Additionally, at least one of the semiconductor elements is disposed between the sensor and the peripheral edge.

Abstract: A payment transaction between a passenger and a driver may be processed using a mobile device of the passenger and a mobile device of the driver. For example, the mobile device of the passenger and the mobile device of the driver may be associated for processing the payment transaction. Fare data for a ride that is offered by the driver may be received from the mobile device that is associated with the driver and payment data for the passenger may be received from the mobile device that is associated with the passenger. A payment processing server may cause the payment transaction to be processed.

Abstract: The invention disclosed herein is directed to compounds of Formula I and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula I, or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a therapeutically effective amount of a selective PPAR? antagonist.

Abstract: A method of forming a ceramic product, the method comprising producing a ceramic foaming mixture in the form of a slurry, causing the slurry to foam, extruding the foamed slurry to produce a plurality of lengths of extruding material each with a diameter of less than 10 mm, firing the extruded material so as to partially sinter the extruded material, forming the partially sintered extruded material into a required shape for a product, and subsequently firing the shaped partially sintered extruded material to form the ceramic product.

Abstract: The invention disclosed herein is directed to compounds of Formula I and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula I, or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a therapeutically effective amount of a selective PPAR? antagonist.

Abstract: The multiple cleat bin of the present invention includes a base, a front wall, two opposing sidewalls, and a substantially vertical rear wall having an upper rim. The rear wall includes a cleat near the upper rim of the rear wall and a second cleat formed at the base of the rear wall. A third cleat formed in the rear wall may also be included. A fourth cleat formed in the rear wall may also be included. Preferably, a forewall and kick out wall are included to form a stacking space such that a second may be placed within bin for increased packing density for shipping or storage. The additional cleats provide additional strength for bins manufactured of more economical or recycled polymers that tend to be softer or less rigid. The use of multiple cleats allows for improved strength and flexibility in use.

Abstract: A clinical predictive and monitoring system comprising a data store operable to receive and store data associated with a plurality of patients selected from medical and health data; and a number of social, behavioral, lifestyle, and economic data; at least one predictive model to identify at least one high-risk patient associated with at least one medical condition; a risk logic module operable to apply the at least one predictive model to the patient data to determine at least one risk score associated the at least one medical condition and identify at least one high-risk patient; a data presentation module operable to present notification and information to an intervention coordination team about the identified at least one high-risk patient; and an artificial intelligence tuning module adapted to automatically adjust parameters in the predictive model in response to trends in the patient data.

Abstract: The invention disclosed herein is directed to compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula (I), or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a of a therapeutically effective amount of a selective PPAR? antagonist.

Abstract: Methods of strengthening the edge surfaces of a glass substrate, and particularly glass substrates contained within a display panel, are disclosed. The methods include exposing edges of the display panel to an acid solution for a time and at a temperature effective to remove no more than about 20 micrometers of glass from edge surfaces, rinsing the acid solution from the edge and applying a polymer protective coating the rinsed edge to maintain the post-etching strength of the edge surfaces. Electronics on the display panel that may be exposed to the acid solution are masked with a terminal mask prior to the etching. The edge etching may be combined with etching of a surface of the display panel/cover glass substrate.

Abstract: Systems, methods and devices for distributed memory management comprising a network component configured for network communication with one or more memory resources that store data and one or more consumer devices that use data, the network component comprising a switching device in operative communication with a mapping resource, wherein the mapping resource is configured to associate mappings between data addresses associated with memory requests from a consumer device relating to a data object and information relating to a storage location in the one or more memory resources associated with the data from the data object, wherein each data address has contained therein identification information for identifying the data from the data object associated with that data address; and the switching device is configured to route memory requests based on the mappings.

Abstract: Embodiments of the present invention provide systems and methods for purifying produced water. The system comprises: a closed loop cation exchange unit, wherein the cation exchange unit comprises a cation resin bed; a closed loop anion exchange unit, wherein the anion exchange unit comprises an anion resin bed; an intermediate degasifer, wherein the cation exchange unit and the anion exchange unit are connected in series through the intermediate degasifier, wherein each of the exchange units further comprises a plurality of treatment zones, wherein the treatment zones comprise at least an adsorption zone, a rinse zone, a regeneration zone and a pulsing zone and a backwash zone; and a rinse tail outlet collector for collecting and removing the rinse fluids from the rinse zone.

Abstract: A new variety of sweetpotato, identified as ‘V12B.445’, is disclosed having disease resistance to both fusarium wilt and Streptomyces soil rot; an orange flesh and purple-red skin, and high yield characteristics.